Crestchem Limited (BOM:526269)
India · Delayed Price · Currency is INR 89.27
-3.73 (-4.01%)
At close: Mar 6, 2026
Crestchem Market Cap
Crestchem has a market cap or net worth of 267.81 million as of March 6, 2026. Its market cap has decreased by -59.48% in one year.
Market Cap
267.81M
Enterprise Value
257.35M
Revenue
266.14M
Ranking
n/a
PE Ratio
12.03
Stock Price
89.27
Market Cap Chart
Since November 1, 2012, Crestchem's market cap has increased from 31.23M to 267.81M, an increase of 757.54%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 267.81M | -20.61% |
| Dec 31, 2025 | 337.35M | -59.85% |
| Dec 31, 2024 | 840.15M | 239.45% |
| Dec 29, 2023 | 247.50M | 38.66% |
| Dec 30, 2022 | 178.50M | 35.69% |
| Dec 31, 2021 | 131.55M | -13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Nutraveda | 1.31B |
| Krebs Biochemicals & Industries | 1.20B |
| Resonance Specialties | 1.13B |
| Tyche Industries | 1.12B |
| Bacil Pharma | 716.93M |
| Vasundhara Rasayans | 381.38M |
| Ishita Drugs and Industries | 202.14M |
| Venmax Drugs and Pharmaceuticals | 185.06M |